Evidence map›Paper›PMID 28651912›Full record

ReviewBioorganic & medicinal chemistry2017

Aligator: A computational tool for optimizing total chemical synthesis of large proteins.

Michael T Jacobsen, Patrick W Erickson, Michael S Kay

Abstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Total chemical synthesis of pentameric cholera toxin subunit B.Chemical communications (Cambridge, England) · 2026
    Article
  2. BracketMaker: Visualization and optimization of chemical protein synthesis.Protein science : a publication of the Protein Society · 2024
    Article
  3. D-Peptide and D-Protein Technology: Recent Advances, Challenges, and Opportunities.Chembiochem : a European journal of chemical biology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael T JacobsenDepartment of Biochemistry, University of Utah School of Medicine, 15 North Medical Drive East, Room 4100, Salt Lake City, UT 84112-5650, United States.
Patrick W EricksonDepartment of Biochemistry, University of Utah School of Medicine, 15 North Medical Drive East, Room 4100, Salt Lake City, UT 84112-5650, United States.
Michael S KayDepartment of Biochemistry, University of Utah School of Medicine, 15 North Medical Drive East, Room 4100, Salt Lake City, UT 84112-5650, United States. Electronic address: kay@biochem.utah.edu.

Funding

D-peptide Inhibitors of HIV-1 EntryR01AI076168 · NIAID · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2008 to 2017
$3.1M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR44AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2015 to 2017
$2.9M
Protease-resistant D-peptide Inhibitors of Ebola Virus EntryR43AI102347 · NIAID · NAVIGEN, INC. · PI WELCH, BRETT D · 2012 to 2013
$600k
D-peptide Inhibitors of HIV-1 EntryR56AI076168 · NIAID · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2012 to 2012
$374k
Characterization and Development of a Coiled-Coil to Treat Non-Hodgkin LymphomaF31CA171677 · NCI · UNIVERSITY OF UTAH · PI JACOBSEN, MICHAEL · 2012 to 2013
$84k
NCI NIH HHS F31 CA171677NIAID NIH HHS R01 AI076168NIAID NIH HHS R43 AI102347NIAID NIH HHS R44 AI102347NIAID NIH HHS R56 AI076168
6 · The paper itself

Abstract

The scope of chemical protein synthesis (CPS) continues to expand, driven primarily by advances in chemical ligation tools (e.g., reversible solubilizing groups and novel ligation chemistries). However, the design of an optimal synthesis route can be an arduous and fickle task due to the large number of theoretically possible, and in many cases problematic, synthetic strategies. In this perspective, we highlight recent CPS tool advances and then introduce a new and easy-to-use program, Aligator (Automated Ligator), for analyzing and designing the most efficient strategies for constructing large targets using CPS. As a model set, we selected the E. coli ribosomal proteins and associated factors for computational analysis. Aligator systematically scores and ranks all feasible synthetic strategies for a particular CPS target. The Aligator script methodically evaluates potential peptide segments for a target using a scoring function that includes solubility, ligation site quality, segment lengths, and number of ligations to provide a ranked list of potential synthetic strategies. We demonstrate the utility of Aligator by analyzing three recent CPS projects from our lab: TNFα (157 aa), GroES (97 aa), and DapA (312 aa). As the limits of CPS are extended, we expect that computational tools will play an increasingly important role in the efficient execution of ambitious CPS projects such as production of a mirror-image ribosome.

Indexed as

SoftwareChaperonin 10Chaperonin 60Computational BiologyEscherichia coliProteinsRibosomal ProteinsTumor Necrosis Factor-alphaChaperonin 10Chaperonin 60ProteinsRibosomal ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID28651912
PMCPMC5860884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.